SlideShare a Scribd company logo
A SPECIALTY CRO
for Phase I – III oncology trialsClinical answers, faster.Clinical answers, faster.
www.medelis.com
www.medelis.com 2
Overview
4/5/2016
Medelis is a specialty oncology CRO that takes pride in building strong relationships with our clients.
Founded in 2003 by a group of
experienced clinical research
oncologists like Dan Von Hoff and
Michael Gordon, we deliver
oncology expertise at the strategic
and tactical level – from protocol
development and regulatory
guidance to site management and
medical writing.
www.medelis.com 3
Expert Guidance
4/5/2016
Board members are actively involved with our study team
providing expertise in:
Study design
Site selection
Patient populations
The latest trends and ideas in oncology drug
development
Regulatory guidance through FDA and EMA
Strategic expertise… available when needed.
4
Operational Oncology Expertise
4/5/2016
Oncology trials are complex. You need an entire team of qualified experts that knows how to handle the
intricacies that arise during an oncology clinical trial.
We are not a training ground for people just starting in clinical
research, or even oncology.
All of our operational resources are highly experienced and have
proven experience in oncology studies.
www.medelis.com
5
Experience Quantified
4/5/2016 www.medelis.com
All clinical operations team members have
at least 10 years
of hands-on experience managing clinical trials
15 years
average length of experience
Our clinical operations team has managed
over 425
clinical trials
over 200
oncology studies
are nurses with oncology training (and many
are former oncology study coordinators)
are physicians and former investigators with hands-
on research experience in managing and evaluating
safety in clinical trials
80% of CRAsOur medical monitors
1 2
3 4
6
Operational Approach
4/5/2016 www.medelis.com
Dedicated project manager for the entire duration of
your trial
Act as a true extension of your team
Flexibility to adapt to and integrate into your team,
processes and systems
7
Operational Approach
4/5/2016 www.medelis.com
Relationships are our #1 priority
Our client’s success is our primary focus - partnerships
breed success
We're not the large CRO that cycles people through trials
and foregoes developing relationships
8
Bid Philosophy
4/5/2016 www.medelis.com
We don’t provide a lowball bid… and
then create change orders throughout
the trial
We bid on the units and services
necessary for the success of your trial
We won’t submit a change order
unless you change the scope of the
trial
9
What This Means for You
4/5/2016 www.medelis.com
Deep oncology experience at each level of your trial
A dedicated project manager
Cost certainty… and unit pricing enables you to quantify costs should
study assumptions change
A proactive and innovative team that anticipates challenges and presents
solutions
A flexible approach… for those times when your goals change midstream
Flexible billing
Cost savings via fixed price, time and materials, unit costs, low overhead,
billing only direct personnel… and no change orders
10
Services
4/5/2016
Sponsor Communication
Study Coordination
Manage Trial Status Reports
Timelines
Budgets
Training
Investigator Meetings
Resource Management
Vendor/Provider
Management
Investigator Grant
Management
Trial Master File
Patient Registration
Negotiate Investigator
Contract & Budgets
Develop Data Monitoring Plan
Conduct Site Training
Site Management
Monitor Subject Enrollment
Manage Site Communication
and Trial Related Issues
Conduct Interim Monitoring
Visits
Evaluate Patient Eligibility
Adverse Event Monitoring
Monitor Drug Accountability
Trial Closure
GCP Quality Process
Site Payment Admin
Feasibility
Investigator Identification
Site Qualification Visits
Regulatory Document Collection
and Review
Budget Negotiations
Contract Negotiations
Evaluate Patient Eligibility
Therapeutic Training of Team
Monitor Patient Safety
Periodic Coding Review
24/7 Medical Coverage
Data Monitoring Committees
Develop Safety Plan
SAE Reporting
IND Safety Alerts
Project Management
Site Management &
Monitoring
Study Start-up
Medical Monitoring &
Safety
Quality Management
11
Services
4/5/2016 www.medelis.com
Review and reconciliation of
complex data: PK, biomarkers,
imaging and other lab data
SAE reconciliation
Clinical review of patient profiles
Narrative review
Review of endpoint assessment
Statistical output review
Protocol deviation review
Sample size calculations
Randomization schemes
Study Design and protocol
development
Statistical analysis plan
Statistical programming using
SAS
Statistical analysis
Statistical reports
Statistical consulting
Statistical representation at FDA
meetings
EDC services provided using
Phase Forward’s Inform EDC
platform
Database build
eCRF development
Edit check programming
Master user list setup
Portal setup
User training
IRT integration
Clinical data management
EDC developers have built >35
trials
CDMs average >10 years
industry experience
Protocol development
Investigator’s Brochures
Informed Consents
Clinical Study Reports
SAE Narratives
Annual Reports
INDs and other regulatory
documents
Expert Clinical
Data Review
Biostatistics
Data
Management
Medical Writing
Quality Management
www.medelis.com 12
Experience
4/5/2016
Deep experience managing Phase I through
Phase IIIs in the United States and Europe
Public & Private
Biotech & Pharmaceutical
Large & Small Governmental
Academic & Institutional
Full service or a la carte project based-work
Experience in almost every oncology indication
Specialization in complex studies
www.medelis.com 13
Company
4/5/2016
Boston, MA
Nashville, TN
European HQ - France
Founded in 2003 by experienced
oncology clinical research
physicians
Full service or a la carte, for phase I
through phase III oncology trials in
US and Europe
Highly experienced oncology team
members and consultants
Solution providers for design and
implementation of innovative,
complex oncology clinical trials
4/5/2016 www.medelis.com 14
David Fox
Vice President, Client Services
(615) 724-4004 david.fox@medelis.com

More Related Content

What's hot

Cortellis for Clinical Trials Message Platform
Cortellis for Clinical Trials Message PlatformCortellis for Clinical Trials Message Platform
Cortellis for Clinical Trials Message Platform
Michael Passanante
 
PC15013_ConferencePreview
PC15013_ConferencePreviewPC15013_ConferencePreview
PC15013_ConferencePreview
Daria Binder
 
Future of RWE Digital Pharma West presentation
Future of RWE Digital Pharma West presentationFuture of RWE Digital Pharma West presentation
Future of RWE Digital Pharma West presentation
Saama
 
Cortellis for CTI external slides
Cortellis for CTI external slidesCortellis for CTI external slides
Cortellis for CTI external slides
Michael Passanante
 
Clinical Research|Clinical Research Organisation|Clinical Development of drugs
Clinical Research|Clinical Research Organisation|Clinical Development of drugsClinical Research|Clinical Research Organisation|Clinical Development of drugs
Clinical Research|Clinical Research Organisation|Clinical Development of drugs
keerthipriya197
 
Marketing Summary - sales presentatioin
Marketing Summary - sales presentatioinMarketing Summary - sales presentatioin
Marketing Summary - sales presentatioin
Michael Passanante
 
Competitive battlecard
Competitive battlecard Competitive battlecard
Competitive battlecard
Michael Passanante
 
The Avoca Quality Consortium Summit 2014 Executive Summary
The Avoca Quality Consortium Summit 2014 Executive SummaryThe Avoca Quality Consortium Summit 2014 Executive Summary
The Avoca Quality Consortium Summit 2014 Executive Summary
The Avoca Group
 
Adaptive Designs for Medical Device Clinical Studies - By Compliance Global ...
Adaptive Designs for Medical Device Clinical Studies  - By Compliance Global ...Adaptive Designs for Medical Device Clinical Studies  - By Compliance Global ...
Adaptive Designs for Medical Device Clinical Studies - By Compliance Global ...
Compliance Global Inc
 
Cortellis for CTI sell sheet
Cortellis for CTI sell sheetCortellis for CTI sell sheet
Cortellis for CTI sell sheet
Michael Passanante
 
Observational Studies: Strategic, Operational and Budgetary Considerations
Observational Studies: Strategic, Operational and Budgetary ConsiderationsObservational Studies: Strategic, Operational and Budgetary Considerations
Observational Studies: Strategic, Operational and Budgetary Considerations
TTC, llc
 
Optimizing Sponsor/CRO Relationships
Optimizing Sponsor/CRO RelationshipsOptimizing Sponsor/CRO Relationships
Optimizing Sponsor/CRO Relationships
Brook White, PMP
 
Need for an Integrated approach to Formulation Research and Knowledge Management
Need for an Integrated approach to Formulation Research and Knowledge ManagementNeed for an Integrated approach to Formulation Research and Knowledge Management
Need for an Integrated approach to Formulation Research and Knowledge Management
Ajaz Hussain
 
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Covance
 
Developments in Clinical Trials
Developments in Clinical TrialsDevelopments in Clinical Trials
Developments in Clinical Trials
Michael Passanante
 
Cortellis for Clinical Trials Intelligence Campaign Overview
Cortellis for Clinical Trials Intelligence Campaign OverviewCortellis for Clinical Trials Intelligence Campaign Overview
Cortellis for Clinical Trials Intelligence Campaign Overview
Michael Passanante
 
Cortellis for CI Slides
Cortellis for CI SlidesCortellis for CI Slides
Cortellis for CI Slides
Michael Passanante
 
Clinical Solutions White Paper
Clinical Solutions White PaperClinical Solutions White Paper
Clinical Solutions White Paper
Michael Passanante
 
CTI Ad
CTI AdCTI Ad
Introduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator ModelIntroduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator Model
Drew Hertig, MBA, CLP
 

What's hot (20)

Cortellis for Clinical Trials Message Platform
Cortellis for Clinical Trials Message PlatformCortellis for Clinical Trials Message Platform
Cortellis for Clinical Trials Message Platform
 
PC15013_ConferencePreview
PC15013_ConferencePreviewPC15013_ConferencePreview
PC15013_ConferencePreview
 
Future of RWE Digital Pharma West presentation
Future of RWE Digital Pharma West presentationFuture of RWE Digital Pharma West presentation
Future of RWE Digital Pharma West presentation
 
Cortellis for CTI external slides
Cortellis for CTI external slidesCortellis for CTI external slides
Cortellis for CTI external slides
 
Clinical Research|Clinical Research Organisation|Clinical Development of drugs
Clinical Research|Clinical Research Organisation|Clinical Development of drugsClinical Research|Clinical Research Organisation|Clinical Development of drugs
Clinical Research|Clinical Research Organisation|Clinical Development of drugs
 
Marketing Summary - sales presentatioin
Marketing Summary - sales presentatioinMarketing Summary - sales presentatioin
Marketing Summary - sales presentatioin
 
Competitive battlecard
Competitive battlecard Competitive battlecard
Competitive battlecard
 
The Avoca Quality Consortium Summit 2014 Executive Summary
The Avoca Quality Consortium Summit 2014 Executive SummaryThe Avoca Quality Consortium Summit 2014 Executive Summary
The Avoca Quality Consortium Summit 2014 Executive Summary
 
Adaptive Designs for Medical Device Clinical Studies - By Compliance Global ...
Adaptive Designs for Medical Device Clinical Studies  - By Compliance Global ...Adaptive Designs for Medical Device Clinical Studies  - By Compliance Global ...
Adaptive Designs for Medical Device Clinical Studies - By Compliance Global ...
 
Cortellis for CTI sell sheet
Cortellis for CTI sell sheetCortellis for CTI sell sheet
Cortellis for CTI sell sheet
 
Observational Studies: Strategic, Operational and Budgetary Considerations
Observational Studies: Strategic, Operational and Budgetary ConsiderationsObservational Studies: Strategic, Operational and Budgetary Considerations
Observational Studies: Strategic, Operational and Budgetary Considerations
 
Optimizing Sponsor/CRO Relationships
Optimizing Sponsor/CRO RelationshipsOptimizing Sponsor/CRO Relationships
Optimizing Sponsor/CRO Relationships
 
Need for an Integrated approach to Formulation Research and Knowledge Management
Need for an Integrated approach to Formulation Research and Knowledge ManagementNeed for an Integrated approach to Formulation Research and Knowledge Management
Need for an Integrated approach to Formulation Research and Knowledge Management
 
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
 
Developments in Clinical Trials
Developments in Clinical TrialsDevelopments in Clinical Trials
Developments in Clinical Trials
 
Cortellis for Clinical Trials Intelligence Campaign Overview
Cortellis for Clinical Trials Intelligence Campaign OverviewCortellis for Clinical Trials Intelligence Campaign Overview
Cortellis for Clinical Trials Intelligence Campaign Overview
 
Cortellis for CI Slides
Cortellis for CI SlidesCortellis for CI Slides
Cortellis for CI Slides
 
Clinical Solutions White Paper
Clinical Solutions White PaperClinical Solutions White Paper
Clinical Solutions White Paper
 
CTI Ad
CTI AdCTI Ad
CTI Ad
 
Introduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator ModelIntroduction to the TSRL, Inc. Accelerator Model
Introduction to the TSRL, Inc. Accelerator Model
 

Viewers also liked

Portfolio Carlos
Portfolio CarlosPortfolio Carlos
Portfolio Carlos
Carlos Candido
 
Jeopardy lesson plan
Jeopardy lesson planJeopardy lesson plan
Jeopardy lesson plan
Adam Boyer
 
презентация для сайту друковані твори (1)
презентация для сайту друковані твори (1)презентация для сайту друковані твори (1)
презентация для сайту друковані твори (1)
irjkf70
 
Powerpoint eu rewinded
Powerpoint eu rewindedPowerpoint eu rewinded
Powerpoint eu rewinded
SLRD
 
Hamacenligne document
Hamacenligne documentHamacenligne document
Hamacenligne document
hamacenligne
 
Medarbetarundersökning.Ledarskap.2013
Medarbetarundersökning.Ledarskap.2013Medarbetarundersökning.Ledarskap.2013
Medarbetarundersökning.Ledarskap.2013Jagannath Tammeleht
 
Gsh-Va Glutatione
Gsh-Va GlutationeGsh-Va Glutatione
Gsh-Va Glutatione
Roberta Russo
 
IBM Cloud : IaaS for developers.
IBM Cloud : IaaS for developers.IBM Cloud : IaaS for developers.
IBM Cloud : IaaS for developers.
Joao Marcelo Barros
 
361 การศึกษาติตตามผลผู้ป่วยที่ได้รับการฟื้นฟูภายหลังการผ่าตัดเปลี่ยนข้อเข่า
361 การศึกษาติตตามผลผู้ป่วยที่ได้รับการฟื้นฟูภายหลังการผ่าตัดเปลี่ยนข้อเข่า361 การศึกษาติตตามผลผู้ป่วยที่ได้รับการฟื้นฟูภายหลังการผ่าตัดเปลี่ยนข้อเข่า
361 การศึกษาติตตามผลผู้ป่วยที่ได้รับการฟื้นฟูภายหลังการผ่าตัดเปลี่ยนข้อเข่าสายชล ชินชัยพงษ์
 
General Electric Presentation
General Electric PresentationGeneral Electric Presentation
General Electric Presentation
MrDBender
 
Morsy, maya salzburg presentation
Morsy, maya   salzburg presentationMorsy, maya   salzburg presentation
Morsy, maya salzburg presentation
Salzburg Global Seminar
 
Why Apex
Why ApexWhy Apex
Why Apex
Stephen Weaver
 
Contador
ContadorContador
Leituras: 17° Domingo do Tempo Comum - Ano B
Leituras: 17° Domingo do Tempo Comum - Ano BLeituras: 17° Domingo do Tempo Comum - Ano B
Leituras: 17° Domingo do Tempo Comum - Ano B
José Lima
 
Diploma Certificate Shaw Academy 230715
Diploma Certificate Shaw Academy 230715Diploma Certificate Shaw Academy 230715
Diploma Certificate Shaw Academy 230715James Saker
 
Certificates
CertificatesCertificates
Certificates
Timothy White
 
"X Encuentros en Educación Infantil"
"X Encuentros en Educación Infantil""X Encuentros en Educación Infantil"
"X Encuentros en Educación Infantil"
InfantilCantabria
 

Viewers also liked (19)

Portfolio Carlos
Portfolio CarlosPortfolio Carlos
Portfolio Carlos
 
Jeopardy lesson plan
Jeopardy lesson planJeopardy lesson plan
Jeopardy lesson plan
 
презентация для сайту друковані твори (1)
презентация для сайту друковані твори (1)презентация для сайту друковані твори (1)
презентация для сайту друковані твори (1)
 
Naldehra
NaldehraNaldehra
Naldehra
 
Powerpoint eu rewinded
Powerpoint eu rewindedPowerpoint eu rewinded
Powerpoint eu rewinded
 
Hamacenligne document
Hamacenligne documentHamacenligne document
Hamacenligne document
 
Medarbetarundersökning.Ledarskap.2013
Medarbetarundersökning.Ledarskap.2013Medarbetarundersökning.Ledarskap.2013
Medarbetarundersökning.Ledarskap.2013
 
Gsh-Va Glutatione
Gsh-Va GlutationeGsh-Va Glutatione
Gsh-Va Glutatione
 
IBM Cloud : IaaS for developers.
IBM Cloud : IaaS for developers.IBM Cloud : IaaS for developers.
IBM Cloud : IaaS for developers.
 
361 การศึกษาติตตามผลผู้ป่วยที่ได้รับการฟื้นฟูภายหลังการผ่าตัดเปลี่ยนข้อเข่า
361 การศึกษาติตตามผลผู้ป่วยที่ได้รับการฟื้นฟูภายหลังการผ่าตัดเปลี่ยนข้อเข่า361 การศึกษาติตตามผลผู้ป่วยที่ได้รับการฟื้นฟูภายหลังการผ่าตัดเปลี่ยนข้อเข่า
361 การศึกษาติตตามผลผู้ป่วยที่ได้รับการฟื้นฟูภายหลังการผ่าตัดเปลี่ยนข้อเข่า
 
General Electric Presentation
General Electric PresentationGeneral Electric Presentation
General Electric Presentation
 
Morsy, maya salzburg presentation
Morsy, maya   salzburg presentationMorsy, maya   salzburg presentation
Morsy, maya salzburg presentation
 
Why Apex
Why ApexWhy Apex
Why Apex
 
NASA ref
NASA refNASA ref
NASA ref
 
Contador
ContadorContador
Contador
 
Leituras: 17° Domingo do Tempo Comum - Ano B
Leituras: 17° Domingo do Tempo Comum - Ano BLeituras: 17° Domingo do Tempo Comum - Ano B
Leituras: 17° Domingo do Tempo Comum - Ano B
 
Diploma Certificate Shaw Academy 230715
Diploma Certificate Shaw Academy 230715Diploma Certificate Shaw Academy 230715
Diploma Certificate Shaw Academy 230715
 
Certificates
CertificatesCertificates
Certificates
 
"X Encuentros en Educación Infantil"
"X Encuentros en Educación Infantil""X Encuentros en Educación Infantil"
"X Encuentros en Educación Infantil"
 

Similar to Medelis Overview - A Specialized Oncology CRO - Q315

Synchrogenix Inc Capabilities Presentation Jan 2010 Final
Synchrogenix Inc Capabilities Presentation Jan  2010 FinalSynchrogenix Inc Capabilities Presentation Jan  2010 Final
Synchrogenix Inc Capabilities Presentation Jan 2010 Final
Johnstrwa
 
Updated capabilities overview1
Updated  capabilities overview1Updated  capabilities overview1
Updated capabilities overview1
malbergo
 
CROS NT Company Overview
CROS NT Company OverviewCROS NT Company Overview
CROS NT Company Overview
CROS NT
 
5 Best Practices in CRO Selection for Biotech
5 Best Practices in CRO Selection for Biotech5 Best Practices in CRO Selection for Biotech
5 Best Practices in CRO Selection for Biotech
Seuss+
 
Brochure
BrochureBrochure
Information support for decision making. Christopher Hart 2012
Information support for decision making. Christopher Hart 2012Information support for decision making. Christopher Hart 2012
Information support for decision making. Christopher Hart 2012
Christopher Hart
 
Study Design to Support Reimbursement
Study Design to Support ReimbursementStudy Design to Support Reimbursement
Study Design to Support Reimbursement
Lyssa Friedman
 
Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10
Lyssa Friedman
 
BMA Presentation 2011_Handout
BMA Presentation 2011_HandoutBMA Presentation 2011_Handout
BMA Presentation 2011_Handout
BMA
 
2014 Avoca Industry Report Executive Summary
2014 Avoca Industry Report Executive Summary 2014 Avoca Industry Report Executive Summary
2014 Avoca Industry Report Executive Summary
The Avoca Group
 
Highlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsHighlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated Trials
ExL Pharma
 
Clinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guidelineClinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guideline
GRCTS
 
BMA Presentation
BMA PresentationBMA Presentation
BMA Presentation
BMA
 
Five Questions to Ask a Prospective CDM Vendor
Five Questions to Ask a Prospective CDM VendorFive Questions to Ask a Prospective CDM Vendor
Five Questions to Ask a Prospective CDM Vendor
CURO Clinical Data Management
 
2017 Projects Kenneth Wu
2017 Projects Kenneth Wu2017 Projects Kenneth Wu
2017 Projects Kenneth Wu
Kenneth Wu
 
Clinical data management training ikyaglobaledu
Clinical data management training   ikyaglobaleduClinical data management training   ikyaglobaledu
Clinical data management training ikyaglobaledu
ikya global
 
Covance Clinical-Biotech: Clinical Trials Designed Around You®
Covance Clinical-Biotech: Clinical Trials Designed Around You®Covance Clinical-Biotech: Clinical Trials Designed Around You®
Covance Clinical-Biotech: Clinical Trials Designed Around You®
Covance
 
UCSF Participant Recruitment Service: Preparing for Launch!
UCSF Participant Recruitment Service: Preparing for Launch!UCSF Participant Recruitment Service: Preparing for Launch!
UCSF Participant Recruitment Service: Preparing for Launch!
CTSI at UCSF
 
Clinical Research Organization Services | Contract Research Company - Pepgra
Clinical Research Organization Services | Contract Research Company - PepgraClinical Research Organization Services | Contract Research Company - Pepgra
Clinical Research Organization Services | Contract Research Company - Pepgra
PEPGRA Healthcare
 
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical Trials
ExL Pharma
 

Similar to Medelis Overview - A Specialized Oncology CRO - Q315 (20)

Synchrogenix Inc Capabilities Presentation Jan 2010 Final
Synchrogenix Inc Capabilities Presentation Jan  2010 FinalSynchrogenix Inc Capabilities Presentation Jan  2010 Final
Synchrogenix Inc Capabilities Presentation Jan 2010 Final
 
Updated capabilities overview1
Updated  capabilities overview1Updated  capabilities overview1
Updated capabilities overview1
 
CROS NT Company Overview
CROS NT Company OverviewCROS NT Company Overview
CROS NT Company Overview
 
5 Best Practices in CRO Selection for Biotech
5 Best Practices in CRO Selection for Biotech5 Best Practices in CRO Selection for Biotech
5 Best Practices in CRO Selection for Biotech
 
Brochure
BrochureBrochure
Brochure
 
Information support for decision making. Christopher Hart 2012
Information support for decision making. Christopher Hart 2012Information support for decision making. Christopher Hart 2012
Information support for decision making. Christopher Hart 2012
 
Study Design to Support Reimbursement
Study Design to Support ReimbursementStudy Design to Support Reimbursement
Study Design to Support Reimbursement
 
Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10Developing the Reimbursement Story 2016-03-10
Developing the Reimbursement Story 2016-03-10
 
BMA Presentation 2011_Handout
BMA Presentation 2011_HandoutBMA Presentation 2011_Handout
BMA Presentation 2011_Handout
 
2014 Avoca Industry Report Executive Summary
2014 Avoca Industry Report Executive Summary 2014 Avoca Industry Report Executive Summary
2014 Avoca Industry Report Executive Summary
 
Highlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated TrialsHighlights from ExL Pharma's 12th Investigator Initiated Trials
Highlights from ExL Pharma's 12th Investigator Initiated Trials
 
Clinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guidelineClinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guideline
 
BMA Presentation
BMA PresentationBMA Presentation
BMA Presentation
 
Five Questions to Ask a Prospective CDM Vendor
Five Questions to Ask a Prospective CDM VendorFive Questions to Ask a Prospective CDM Vendor
Five Questions to Ask a Prospective CDM Vendor
 
2017 Projects Kenneth Wu
2017 Projects Kenneth Wu2017 Projects Kenneth Wu
2017 Projects Kenneth Wu
 
Clinical data management training ikyaglobaledu
Clinical data management training   ikyaglobaleduClinical data management training   ikyaglobaledu
Clinical data management training ikyaglobaledu
 
Covance Clinical-Biotech: Clinical Trials Designed Around You®
Covance Clinical-Biotech: Clinical Trials Designed Around You®Covance Clinical-Biotech: Clinical Trials Designed Around You®
Covance Clinical-Biotech: Clinical Trials Designed Around You®
 
UCSF Participant Recruitment Service: Preparing for Launch!
UCSF Participant Recruitment Service: Preparing for Launch!UCSF Participant Recruitment Service: Preparing for Launch!
UCSF Participant Recruitment Service: Preparing for Launch!
 
Clinical Research Organization Services | Contract Research Company - Pepgra
Clinical Research Organization Services | Contract Research Company - PepgraClinical Research Organization Services | Contract Research Company - Pepgra
Clinical Research Organization Services | Contract Research Company - Pepgra
 
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical Trials
 

Medelis Overview - A Specialized Oncology CRO - Q315

  • 1. A SPECIALTY CRO for Phase I – III oncology trialsClinical answers, faster.Clinical answers, faster. www.medelis.com
  • 2. www.medelis.com 2 Overview 4/5/2016 Medelis is a specialty oncology CRO that takes pride in building strong relationships with our clients. Founded in 2003 by a group of experienced clinical research oncologists like Dan Von Hoff and Michael Gordon, we deliver oncology expertise at the strategic and tactical level – from protocol development and regulatory guidance to site management and medical writing.
  • 3. www.medelis.com 3 Expert Guidance 4/5/2016 Board members are actively involved with our study team providing expertise in: Study design Site selection Patient populations The latest trends and ideas in oncology drug development Regulatory guidance through FDA and EMA Strategic expertise… available when needed.
  • 4. 4 Operational Oncology Expertise 4/5/2016 Oncology trials are complex. You need an entire team of qualified experts that knows how to handle the intricacies that arise during an oncology clinical trial. We are not a training ground for people just starting in clinical research, or even oncology. All of our operational resources are highly experienced and have proven experience in oncology studies. www.medelis.com
  • 5. 5 Experience Quantified 4/5/2016 www.medelis.com All clinical operations team members have at least 10 years of hands-on experience managing clinical trials 15 years average length of experience Our clinical operations team has managed over 425 clinical trials over 200 oncology studies are nurses with oncology training (and many are former oncology study coordinators) are physicians and former investigators with hands- on research experience in managing and evaluating safety in clinical trials 80% of CRAsOur medical monitors 1 2 3 4
  • 6. 6 Operational Approach 4/5/2016 www.medelis.com Dedicated project manager for the entire duration of your trial Act as a true extension of your team Flexibility to adapt to and integrate into your team, processes and systems
  • 7. 7 Operational Approach 4/5/2016 www.medelis.com Relationships are our #1 priority Our client’s success is our primary focus - partnerships breed success We're not the large CRO that cycles people through trials and foregoes developing relationships
  • 8. 8 Bid Philosophy 4/5/2016 www.medelis.com We don’t provide a lowball bid… and then create change orders throughout the trial We bid on the units and services necessary for the success of your trial We won’t submit a change order unless you change the scope of the trial
  • 9. 9 What This Means for You 4/5/2016 www.medelis.com Deep oncology experience at each level of your trial A dedicated project manager Cost certainty… and unit pricing enables you to quantify costs should study assumptions change A proactive and innovative team that anticipates challenges and presents solutions A flexible approach… for those times when your goals change midstream Flexible billing Cost savings via fixed price, time and materials, unit costs, low overhead, billing only direct personnel… and no change orders
  • 10. 10 Services 4/5/2016 Sponsor Communication Study Coordination Manage Trial Status Reports Timelines Budgets Training Investigator Meetings Resource Management Vendor/Provider Management Investigator Grant Management Trial Master File Patient Registration Negotiate Investigator Contract & Budgets Develop Data Monitoring Plan Conduct Site Training Site Management Monitor Subject Enrollment Manage Site Communication and Trial Related Issues Conduct Interim Monitoring Visits Evaluate Patient Eligibility Adverse Event Monitoring Monitor Drug Accountability Trial Closure GCP Quality Process Site Payment Admin Feasibility Investigator Identification Site Qualification Visits Regulatory Document Collection and Review Budget Negotiations Contract Negotiations Evaluate Patient Eligibility Therapeutic Training of Team Monitor Patient Safety Periodic Coding Review 24/7 Medical Coverage Data Monitoring Committees Develop Safety Plan SAE Reporting IND Safety Alerts Project Management Site Management & Monitoring Study Start-up Medical Monitoring & Safety Quality Management
  • 11. 11 Services 4/5/2016 www.medelis.com Review and reconciliation of complex data: PK, biomarkers, imaging and other lab data SAE reconciliation Clinical review of patient profiles Narrative review Review of endpoint assessment Statistical output review Protocol deviation review Sample size calculations Randomization schemes Study Design and protocol development Statistical analysis plan Statistical programming using SAS Statistical analysis Statistical reports Statistical consulting Statistical representation at FDA meetings EDC services provided using Phase Forward’s Inform EDC platform Database build eCRF development Edit check programming Master user list setup Portal setup User training IRT integration Clinical data management EDC developers have built >35 trials CDMs average >10 years industry experience Protocol development Investigator’s Brochures Informed Consents Clinical Study Reports SAE Narratives Annual Reports INDs and other regulatory documents Expert Clinical Data Review Biostatistics Data Management Medical Writing Quality Management
  • 12. www.medelis.com 12 Experience 4/5/2016 Deep experience managing Phase I through Phase IIIs in the United States and Europe Public & Private Biotech & Pharmaceutical Large & Small Governmental Academic & Institutional Full service or a la carte project based-work Experience in almost every oncology indication Specialization in complex studies
  • 13. www.medelis.com 13 Company 4/5/2016 Boston, MA Nashville, TN European HQ - France Founded in 2003 by experienced oncology clinical research physicians Full service or a la carte, for phase I through phase III oncology trials in US and Europe Highly experienced oncology team members and consultants Solution providers for design and implementation of innovative, complex oncology clinical trials
  • 14. 4/5/2016 www.medelis.com 14 David Fox Vice President, Client Services (615) 724-4004 david.fox@medelis.com